` Comparison: 7XP vs ROG - Alpha Spread

7XP
vs
ROG

Over the past 12 months, 7XP has underperformed ROG, delivering a return of -61% compared to the ROG's +10% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
7XP
ROG
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

7XP Intrinsic Value
LOCKED
Unlock
ROG Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Organon & Co
XMUN:7XP
5.112 EUR
Roche Holding AG
SIX:ROG
314.7 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
7XP, ROG

7XP
ROG
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Organon & Co
Revenue
Roche Holding AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
7XP, ROG

7XP
ROG
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Organon & Co
XMUN:7XP
Roche Holding AG
SIX:ROG
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

7XP
53.3%
ROG
73.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

Operating Margin

7XP
21.6%
ROG
35%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

Net Margin

7XP
3%
ROG
20.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

FCF Margin

7XP
6.2%
ROG
17.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

ROE

7XP
30.6%
ROG
39.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

ROA

7XP
1.4%
ROG
12.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

ROIC

7XP
5.2%
ROG
19.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

ROCE

7XP
12.9%
ROG
29.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Organon & Co
Roche Holding AG

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
7XP, ROG

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
7XP, ROG

Performance Gap Between 7XP and ROG
LOCKED
Unlock

Performance By Year
7XP, ROG

Loading
7XP
ROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 7XP to other stocks
LLY
Eli Lilly and Co
More expensive
vs 7XP
JNJ
Johnson & Johnson
More expensive
vs 7XP
AZN
AstraZeneca PLC
More expensive
vs 7XP
MRK
Merck & Co Inc
More expensive
vs 7XP
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett